Sumitomo Chemical Co., Ltd. is a major Japanese chemical company whose Advanced Medical Solutions Sector provides CDMO services for small molecule APIs and intermediates, oligonucleotide production (including gRNA for genome editing), and regenerative medicine/cell therapies through its S-RACMO joint venture with Sumitomo Pharma. The company also operates large agrochemical, IT materials, and essential materials businesses.
small molecule API and intermediate manufacturing, long-chain oligonucleotide synthesis (gRNA), regenerative medicine/cell therapy (via S-RACMO JV), advanced organic synthesis
1 site worldwide
Involvement in 18 clinical trials
No reviews available yet.
No documents available.